Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...
Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...
For more than 40 years, Florida Cancer Specialists & Research Institute (FCS) has embraced innovation to deliver world-class care and drive the dramatic transformation of oncology care through its ...
Last year, Novartis debuted its first-ever Super Bowl ad with an aim of starting “a movement” around early breast cancer ...
8don MSN
Israeli hospital's groundbreaking studies could lessen treatments, reduce prostate cancer risks
A groundbreaking study at Rabin Medical Center suggests prostate cancer patients may need only two radiation doses, ...
PRESS RELEASEAB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES PATENT COVERING MASITINIB IN THE TREATMENT OF METASTATIC CASTRATE ...
From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...
NHS England has announced that men whose high-risk prostate cancer has not yet spread will be able to receive the drug, ...
North East patients are among the first in the UK to trial Lutetium (177Lu) rhPSMA-10.1, a new targeted treatment for ...
Research shows that eating a plant-based diet may offer protective benefits for heart health and prevention against certain ...
Cleveland Clinic has formed a new Center for Genitourinary (GU) Malignancies Research, which will focus on advancing discoveries to better understand, diagnose and treat cancer of the prostate, ...
Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results